The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Human lymphocyte metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin
Open accessAbstract
The effects of extracellular nucleotides and agents which elevate intracellular cyclic adenosine 3',5'-monophosphate (cyclic AMP) concentrations on human lymphocyte metabolism have been studied. Aminophylline, isoproterenol, and prostaglandins, all of which elevate lymphocyte cyclic AMP levels, inhibited incorporation of (3)H-labeled thymidine, uridine, and leucine into the DNA, RNA, and protein of phytohemagglutinin (PHA)-stimulated lymphocytes. Aminophylline inhibition was maximal only when the inhibitor was added within 1 hr after exposure of cells to PHA, suggesting that a relatively early step in the lymphocyte transformation process may be affected. The addition of various nucleotides to the culture medium also inhibited incorporation of labeled precursors. The best inhibitor, dibutyryl cyclic AMP (DU cyclic AMP), produced maximal inhibition only if present during the 1st hr after initial exposure to PHA. Among the various cyclic nucleotides derivatives of guanosine and adenine were the most effective inhibitors (substantial inhibition at 0.1 mM concentrations). However, the inhibition was not specific for nucleotides containing the cyclic phosphodiester moiety since the tri-, di-, and monophosphates of adenosine and guanosine were equally effective in diminishing thymidine uptake. The above inhibitions were not due to secondary effects of the inhibitors on the interaction of PHA with lymphocytes as judged by (125)I-labeled PHA binding studies.Low concentrations (1-10 mumoles/liter) of cyclic AMP produced slight stimulation of thymidine-(3)H uptake in resting lymphocytes (lymphocytes not stimulated with PHA). However, the effects were quite small as compared with those produced by PHA itself. Attempts to demonstrate increased thymidine uptake 48 hr after pulsing lymphocytes with aminophylline or isoproterenol were unsuccessful. The relationship of these observations to a possible regulatory role for cyclic AMP in PHA-stimulated lymphocytes is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Some Aspects of the Biological Role of Adenosine 3',5'-monophosphate (Cyclic AMP)
SUTHERLAND, E. W., ROBISON, G. A., & BUTCHER, R. W. (1968) · Circulation · doi:10.1161/01.cir.37.2.279 · Cited by 965
The Structure of a Phytohemagglutinin Receptor Site from Human Erythrocytes
Kornfeld, R., & Kornfeld, S. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63104-7 · Cited by 348
Inhibition of Cell Growth in vitro by Adenosine 3′,5′-Monophosphate
Ryan, W. L., & Heidrick, M. L. (1968) · Science · doi:10.1126/science.162.3861.1484 · Cited by 244
Dutton, R. W., & Eady, J. D. (1964) · PubMed · Cited by 183
Decreased phytohemagglutinin receptor sites in chronic lymphocytic leukemia
Kornfeld, S. (1969) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(69)90409-7 · Cited by 85
Cited by
Bourne, H. R., Weinstein, Y., Melmon, K. L., Lichtenstein, L. M., Henney, C. S., & Shearer, G. M. (1974) · Science · doi:10.1126/science.184.4132.19 · Cited by 914
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Webb, D. R. (1980) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(80)90024-0 · Cited by 768
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Ceuppens, J. (1983) · Journal of Clinical Immunology · doi:10.1007/bf00915791 · Cited by 715
Huang, S., Apasov, S., Koshiba, M., & Sitkovsky, M. (1997) · Blood · doi:10.1182/blood.v90.4.1600 · Cited by 531
Unanue, E. R. (1981) · Advances in Immunology · doi:10.1016/s0065-2776(08)60919-0 · Cited by 511
Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.
Kurland, J. I., & Bockman, R. (1978) · The Journal of experimental medicine · doi:10.1084/jem.147.3.952 · Cited by 482
Nutritional Modulation of Immune Function: Analysis of Evidence, Mechanisms, and Clinical Relevance
Wu, D., Lewis, E. D., Pae, M., & Meydani, S. N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03160 · Cited by 481
Anti-Inflammatory Drugs in the 21st Century
Rainsford, K. D. (2007) · Subcellular Biochemistry · doi:10.1007/1-4020-5688-5_1 · Cited by 463
The structure and function of CD26 in the T‐cell immune response
Morimoto, C., & Schlossman, S. F. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01571.x · Cited by 421
Regulatory role of vitamin E in the immune system and inflammation
Lewis, E. D., Meydani, S. N., & Wu, D. (2019) · IUBMB Life · doi:10.1002/iub.1976 · Cited by 406
Autonomic Nervous System and Immune System Interactions
Kenney, M. J., & Ganta, C. K. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130051 · Cited by 381
Keller, S. E., Weiss, J. M., Schleifer, S. J., Miller, N. E., & Stein, M. (1981) · Science · doi:10.1126/science.6973822 · Cited by 353
Prostaglandins and cancer: A review of tumor initiation through tumor metastasis
Honn, K. V., Bockman, R. S., & Marnett, L. J. (1981) · Prostaglandins · doi:10.1016/0090-6980(81)90240-9 · Cited by 269
Sympathetic modulation of immunity: Relevance to disease
Bellinger, D. L., Millar, B. A., Perez, S., Carter, J., Wood, C., ThyagaRajan, S., Molinaro, C., Lubahn, C., & Lorton, D. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.09.005 · Cited by 254
Metadata
- Authors
- Smith, J. W., Steiner, A. L., & Parker, C. W.
- Venue
- Journal of Clinical Investigation
- Published
- 1971-02-01
- Volume
- 50
- Issue
- 2
- Pages
- 442-448
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2119835942
- Cited by
- 395
- References
- 5
- FWCI
- 12.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.